Guardant Health Inc (GH) Q4 2025 Earnings Call Transcript

Why It Matters

The results highlight GE HealthCare’s resilient demand and cash generation despite tariff pressures, while its guidance and acquisition strategy signal continued growth and margin expansion for investors.

Key Takeaways

• Q4 revenue $5.7B, 4.8% organic growth.
• Record backlog $21.8B, book‑to‑bill 1.06.
• Adjusted EBIT margin 16.7%, down 200 bps tariffs.
• 2026 outlook: 3‑4% growth, EPS $4.95‑$5.15.
• IntelliRed adds $270M revenue, >30% EBITDA.

Pulse Analysis

GE HealthCare’s fourth‑quarter performance underscores its strong market position in diagnostic imaging and precision care. Revenue rose to $5.7 billion, driven by double‑digit growth in pharmaceutical diagnostics and solid gains across imaging and advanced visualization solutions. A record $21.8 billion backlog and a book‑to‑bill ratio above one reflect robust order inflow, particularly from large enterprise agreements in the US and EMEA. These fundamentals provide a stable platform for the company’s medium‑term targets of mid‑single‑digit revenue growth and high‑teen EBIT margins.

Tariff exposure emerged as the primary headwind, trimming adjusted EBIT margin by 200 basis points and pulling adjusted EPS down 0.7%. Management mitigated this impact through the Heartbeat Business System, shifting production lines to lower‑cost geographies and partnering with contract manufacturers to improve flexibility. These operational adjustments, combined with $1.7 billion in targeted innovation spend, helped preserve cash flow, delivering $916 million in free cash flow and a 72% conversion rate. The focus on productivity and SG&A optimization positions the firm to rebound from tariff‑related margin pressure while sustaining its investment pipeline.

Looking ahead, GE HealthCare projects 3‑4% organic revenue growth in 2026, with EBIT margin expansion to 15.8‑16.1% and EPS between $4.95 and $5.15. The company remains cautious on China demand but expects foreign‑exchange benefits and continued service revenue growth to offset regional softness. The recent IntelliRed acquisition, slated to generate $270 million in its first full year and deliver EBITDA above 30%, will deepen the firm’s cloud‑first imaging ecosystem and accelerate recurring SaaS revenue. Together, these strategic moves aim to enhance visibility, improve margin resilience, and drive long‑term shareholder value.